Earnings estimates for the S&P 500 holding up better than normal is one of the key reasons Wall Street strategists are optimistic about the path for stocks in the second half of 2024.
Other sectors have rallied on AI demand, raising the stakes for the chipmaker's latest quarterly update.
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.